CD274 and ovarian carcinoma: Further study showed that the destruction of PD-L1 on tumor cells could increase tumor infiltrating lymphocytes (TILs) and regulate cytokine/chemokine distribution in the tumor microenvironment (TME), thus promoting anti-tumor immunity and inhibiting the ovarian cancer progression (59).